Session slides can be found below each session title. Please note that not all sessions have slides available.

7:30 – 8:30 Registration and Continental Breakfast

8:30 – 8:45 Welcome

Lori Alvarado, CEO, DCCCA

Secretary Laura Howard, Kansas Department for Aging and Disability Services

Joan Duwve, M.D. Acting State Health Officer, Kansas Department of Health and Environment

8:45 – 10:30 Keynote Speakers

The Opioid Crisis and Psychostimulants– National and State Perspectives and Initiatives
Slides here

Ann M. Elifrits, MS, LCP, LCAC SUD/Overdose Prevention Director, Kansas Department of Health and Environment (KDHE) and Julia Baughman SUD/Overdose Prevention Program Manager, KDHE

Developing An Upstream Approach To Our Nation’s Substance Use Disorder Crisis
Slides here

Nicole Augustine, MPH, MCHES, CPS Advanced Implementation Specialist, Opioid Response Network; Owner, RIZE Consultants

10:45 – 11:30 Breakout Session 1

Differences in Post-Operative Pain Outcomes Following Orthopedic Surgery Considering Gender and Exogenous Hormone Use
Slides here

Haley Albers, Medical Student, University of Kansas School of Medicine

Law Enforcement Naloxone Policy Panel

Daniel Donovan, Prevention Specialist, DCCCA

Recovery-Oriented Systems of Care: Saving Lives, Reclaiming Futures
Slides here

Shawn Billings, VP of Substance Use Programming, MO Hospital Association and Jennifer Wolfe, Certified Peer Specialist, EPICC/CommCARE

Stimulant Use Disorder Regarding Trends and Treatment Options – Part One
Slides available upon request

Dr. Richard Rawson, Ph.D. Professor Emeritus, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA; Research Professor, Vermont Center for Behavior and Health, University of Vermont

Certified Community Behavioral Health Clinics (CCBHC) Overview
Slides here

Drew Adkins, Assistant Commissioner, Behavioral Health Services Commission, Kansas Department for Aging and Disability Services

Drug Endangered Children (DEC) and Creating Community Alliances
Slides here

Jennifer Gassmann, Parent Child Assistance Program Supervisor, Kansas Children’s Service League and Michael Parsons, Prevention Program Coordinator, DCCCA

Kansas Prescription Drug and Opioid Advisory Committee: State Strategic Planning Update
Slides here

Adrienne Hearrell, MPH, CPTA, PA-S1 Advanced Public Health Solutions and Alyssa Nava, MPH Prevention Specialist, DCCCA

11:45 – 12:30 Breakout Session 2

Opioid Safety and Disposal Interventions

Dr. Aaron LacKamp, MD Associate Professor of Anesthesiology and Neurology, University of Kansas School of Medicine

Leveraging ODMAP for Overdose Prevention
Slides here

DJ Gering, MA Public Health Analyst, Midwest HIDTA, CDC Foundation and Todd Hixson Drug Intelligence Officer, Midwest HIDTA, CDC Foundation

ASAM Criteria, Treatment Placement & Clinical Documentation
Slides here

Emily Swanzy Manager of Clinical Services, Beacon Health Options

Stimulant Use Disorder Regarding Trends and Treatment Options – Part Two
Slides available upon request

Naloxone Training and Policy for First Responders
Slides here

Daniel Donovan, Prevention Specialist, DCCCA

Cross Sector Collaboration – Empowering Communities to Lead the Change
Slides here

Seth Dewey Public Health Educator, Reno County Health Department; Co-Founder, Kansas Recovery Network

The Opioid Crisis – How Can I help?
Slides here

Ann M. Elifrits, MS, LCP, LCAC SUD/Overdose Prevention Director, Kansas Department of Health and Environment (KDHE) and Julia Baughman SUD/Overdose Prevention Program Manager, KDHE

12:30 – 1:30 Lunch – Provided

1:30 – 2:15 Breakout Session 3

KTRACS: Prescribing and You
Slides here

Gayle Donaldson, MBA Assistant Director, Kansas Board of Pharmacy (KBOP) and LaTonyua Rice, PharmD, BCGP KTRACS Clinical Pharmacist, KBOP

Kansas Drug Diversion from within Long Term Care Facilities

Lauren Wolf, RN Senior Registered Nurse Investigator, Kansas Attorney General’s Office, Medicaid Fraud and Abuse

Sustaining Recovery Through Work
Slides here

Shara Gonzales, President and CEO, New Beginning, Inc.

Overview of Kansas Stimulant Overdose Data
Slides here

Scott Johnston, MPH Drug Overdose Epidemiologist, Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment

Best Practices for OUD and Lessons Learned Across Multiple Midwestern States
Slides here

Jessica Johnson, Manager, Behavioral Health and Wellness, CareSource

Controlled Substance Diversion in Veterinary Medicine
Slides here

Dr. Steven Seiler, Ph.D. Professor and Director, Tennessee Tech University and Dr. Meggan Graves, DVM Clinical Associate Professor, University of Tennessee College of Veterinary Medicine

Opioid Settlement Funding Session
Slides here

Chris Teters, Assistant Attorney General, Consumer Protection Division, Kansas Attorney General’s Office

2:30 – 3:15 Breakout Session 4

Expanding Recovery-Oriented Systems of Care in Rural Communities

April Jackson, Rural Health Coordinator, Thrive Allen County

CKF Provision of SUD Treatment via Telehealth: A Positive Impact of the Pandemic
Slides here

Shane Hudson, MS, MSHCT, LCP, LCAC President and CEO, CKF Addiction Treatment

Fentanyl Death Investigations
Slides here

Mike Long, Detective, Johnson County Sheriff’s Office

Updates on 988 in Kansas

Brooks Robertson, Behavioral Health Liaison, Kansas Suicide Prevention Headquarters

Drugs in the Age of Fentanyl

Libby Davis, MSN Keepin’ It Clean for Coop

Pain Management in Women – The Impacts of Sex and Gender

Dr. Kim Templeton, MD, FAAOS, FAOA, FAMWA Professor, Orthopedic Surgery and Sports Medicine, University of Kansas School of Medicine

Dealing with Fakes: The Rise of Counterfeit Pills and Their Impacts on Medical Treatment for Substance Use Disorder
Slides here

Dr. Daniel Warren, MD Assistant Professor, University of Kansas School of Medicine and Dr. Ashley Haynes, MD Ascension Via Christi Hospitals

3:30 – 4:45 Closing Keynote Session and Conference Close

Patient Journey Map: Listening to the Voices of Patients in Recovery
Slides here

Kayla Zawislak, MSW, CADC, Director of Patient Engagement, Addiction Policy Forum

Sessions by Track

General Topic:

Opioid Settlement Funding Session
Chris Teters, Assistant Attorney General, Consumer Protection Division, Kansas Attorney General’s Office

Dealing with Fakes: The Rise of Counterfeit Pills and Their Impacts on Medical Treatment for Substance Use Disorder
Dr. Daniel Warren, MD Assistant Professor, University of Kansas School of Medicine and Dr. Ashley Haynes, MD Ascension Via Christi Hospitals

Differences in Post-Operative Pain Outcomes Following Orthopedic Surgery Considering Gender and Exogenous Hormone Use
Haley Albers, Medical Student, University of Kansas School of Medicine

KTRACS: Prescribing & You
Gayle Donaldson, MBA Assistant Director, Kansas Board of Pharmacy (KBOP) and LaTonyua Rice, PharmD, BCGP KTRACS Clinical Pharmacist, KBOP

Opioid Safety and Disposal Interventions
Dr. Aaron LacKamp, MD Associate Professor of Anesthesiology and Neurology, University of Kansas School of Medicine

Pain Management in Women – The Impacts of Sex and Gender
Dr. Kim Templeton, MD, FAAOS, FAOA, FAMWA Professor, Orthopedic Surgery and Sports Medicine, University of Kansas School of Medicine

ASAM Criteria, Treatment Placement & Clinical Documentation
Emily Swanzy, Manager of Clinical Services, Beacon Health Options

Certified Community Behavioral Health Clinics (CCBHC) Overview
Drew Adkins, Assistant Commissioner, Behavioral Health Services Commission, Kansas Department for Aging and Disability Services

CKF Provision of SUD Treatment via Telehealth: A Positive Impact of the Pandemic
Shane Hudson, MS, MSHCT, LCP, LCAC President and CEO, CKF Addiction Treatment

Expanding Recovery-Oriented Systems of Care in Rural Communities
April Jackson, Rural Health Coordinator, Thrive Allen County

Recovery-Oriented Systems of Care: Saving Lives, Reclaiming Futures
Shawn Billings, VP of Substance Use Programming, MO Hospital Association and Jennifer Wolfe, Certified Peer Specialist, EPICC/CommCARE

Sustaining Recovery Through Work
Shara Gonzales, President and CEO, New Beginning, Inc.

Best Practices for OUD and Lessons Learned Across Multiple Midwestern States
Jessica Johnson, Manager, Behavioral Health and Wellness, CareSource

Controlled Substance Diversion in Veterinary Medicine
Dr. Steven Seiler, Ph.D. Professor and Director, Tennessee Tech University and Dr. Meggan Graves, DVM Clinical Associate Professor, University of Tennessee College of Veterinary Medicine

Cross Sector Collaboration – Empowering Communities to Lead the Change
Seth Dewey Public Health Educator, Reno County Health Department; Co-Founder, Kansas Recovery Network

Drug Endangered Children (DEC) and Creating Community Alliances
Jennifer Gassmann, Parent Child Assistance Program Supervisor, Kansas Children’s Service League and Michael Parsons, Prevention Program Coordinator, DCCCA

Drugs in the Age of Fentanyl
Libby Davis, MSN Keepin’ It Clean for Coop

Kansas Prescription Drug and Opioid Advisory Committee: State Strategic Planning Update
Adrienne Hearrell, MPH, CPTA, PA-S1 Advanced Public Health Solutions and Alyssa Nava, MPH Prevention Specialist, DCCCA

The Opioid Crisis: How Can I Help?
Ann M. Elifrits, MS, LCP, LCAC SUD/Overdose Prevention Director, Kansas Department of Health and Environment (KDHE) and Julia Baughman SUD/Overdose Prevention Program Manager, KDHE

Updates on 988 in Kansas
Brooks Robertson, Behavioral Health Liaison, Kansas Suicide Prevention Headquarters

Fentanyl Death Investigations
Mike Long, Detective, Johnson County Sheriff’s Office

Kansas Drug Diversion from within Long Term Care Facilities
Lauren Wolf, RN Senior Registered Nurse Investigator, Kansas Attorney General’s Office, Medicaid Fraud and Abuse

Law Enforcement Naloxone Policy Panel
Daniel Donovan, Prevention Specialist, DCCCA

Leveraging ODMAP for Overdose Prevention
DJ Gering, MA Public Health Analyst, Midwest HIDTA, CDC Foundation and Todd Hixson Drug Intelligence Officer, Midwest HIDTA, CDC Foundation

Naloxone Training and Policy for First Responders
Daniel Donovan, Prevention Specialist, DCCCA

Overview of Kansas Stimulant Overdose Data
Scott Johnston, MPH Drug Overdose Epidemiologist, Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment

Stimulant Use Disorder Regarding Trends and Treatment Options – Part One
Dr. Richard Rawson, Ph.D. Professor Emeritus, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA; Research Professor, Vermont Center for Behavior and Health, University of Vermont

Stimulant Use Disorder Regarding Trends and Treatment Options – Part Two
Dr. Richard Rawson, Ph.D. Professor Emeritus, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA; Research Professor, Vermont Center for Behavior and Health, University of Vermont